Please login to the form below

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

US-based, Ridgeback is focused on emerging infectious diseases and markets monoclonal antibody Ebanga (ansuvimab-zykl) for the treatment of Ebola.

Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales

Elsewhere, Pfizer reported a 25% increase in sales for anticoagulant med Eliquis, led by growth in the US, emerging markets and developed Europe, as well as an 88% operational growth for ... Pfizer’s Janus kinase (JAK) inhibitor Xeljanz also grew by 18%
Edging towards success

Where to look. As I research the success of business models in biomedical markets, I can see emerging examples of ‘white edges’ being won and lost.
PMEA 2020: continuing to recognise excellence in improving patient outcomes

3, Excellence in Collaboration and Partnerships. Sponsored by Sanofi Genzyme. Winner: AstraZeneca Emerging Markets Health Innovation Hubs: Reimagining Patient Experiences and Improving Health Outcomes Through Unique Collaborations by AstraZeneca.
Takeda to sell Japan consumer health unit for $2.3bn

This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
AstraZeneca’s Farxiga scores another FDA fast-track designation

That’s an increase of 14% at a constant exchange rate, thanks mostly to sales increases in emerging markets including China.

More from news
Approximately 13 fully matching, plus 357 partially matching documents found.

Back to the future

Business models that aimed to compete on customer intimacy were polarising between small audiences – so called health concierges – and mass markets, which is Fitbit’s emerging model. ... By and large, I feel pretty vindicated. The six great shifts
Pharma funding and M&A in 2020

As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.
BRIC markets

The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.
The mission matters

Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and
Leading AstraZeneca’s return to growth in Europe

Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there

More from intelligence
Approximately 14 fully matching, plus 62 partially matching documents found.

New faces at JPA Health Communications, GCI Health and HRW

Her more recent focus has been in conducting business in emerging markets. ... In the newly created global director role, Rees will focus on expanding the business across the company, as well as developing business opportunities in emerging markets.
Pfizer names Albert Bourla as COO

regional head for US vaccines, vice president for emerging markets for primary care and vice president of the US brands business within essential health.
Sobi appoints Torbjorn Hallberg as general counsel

Hallberg, who joins from Takeda, where he served for seven years, first as senior director and corporate counsel and then more recently as its vice president, general counsel for emerging markets.
Paolo Carli appointed as head of MEA at Merck

emerging markets.
Neovii Pharmaceuticals promotes Juergen Pohle to CEO

Prior to joining Neovii he headed up Novartis’ emerging growth markets and institutional customers businesses.

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Breaking the silence: It’s time to talk about the menopause

We are experts in Female Health and have conducted over 80 projects covering a wide range of global markets. ... In addition, we have specialised Emerging Markets and Behavioural Science teams, who we work in collaboration with to help pharmaceutical
Webcast: China Update 2023: How will recent developments impact your brand’s success?

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.
What does the future hold for Light-chain Amyloidosis?

We found spontaneous awareness of new developments and approvals to be very limited in all markets. ... In addition, we have specialised Emerging Markets and Behavioural Science teams, who we work in collaboration with to help pharmaceutical clients
How femtech is changing the future of women's health

Women’s health and the next billion users. For femtech, the next big challenge and the next big opportunity is the emerging markets.
Webcast

China: How pharma can maximize success in this rapidly changing emerging market. ... Watch this webcast in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of COVID-19,

More from PMHub
Approximately 61 fully matching, plus 37 partially matching documents found.

No results were found

Add my company

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

New Playbook Alert: Virtual Patient Engagement: ...
Millennials: the wellness generation: Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help): While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....

Email:
Password: